Longeveron Inc

LGVN04 Dec 2024
Healthcare
$2.03
-0.01 (-1.36%)
Lowest Today
$1.98
Highest Today
$2.04
Today’s Open
$2.03
Prev. Close
$2.01
52 Week High
$23.9
52 Week Low
$0.77
To Invest in Longeveron Inc

Longeveron Inc

Healthcare
LGVN04 Dec 2024
-0.01 (-1.36%)
1M
3M
6M
1Y
5Y
Low
$1.98
Day’s Range
High
$2.04
1.98
52 Week Low
$0.77
52-Week Range
52 Week High
$23.9
0.77
1 Day
-
1 Week
-2.66%
1 month return
-7.6%
3 month return
-8.02%
6 month return
+94.66%
1 Year return
-90.29%
3 Years return
-98.98%
5 Years return
-
10 Years return
-
Institutional Holdings
Geode Capital Management, LLC
0.87
Fidelity Extended Market Index
0.5
Vanguard Group Inc
0.3
Vanguard Institutional Extnd Mkt Idx Tr
0.3
Capital Investment Advisory Services, LLC
0.18
Fidelity Total Market Index
0.16
Fidelity Series Total Market Index
0.12

Market Status

Fundamentals
Market Cap
30.56 mln
PB Ratio
1.19
PE Ratio
0
Enterprise Value
9.38 mln
Total Assets
12.08 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Organisation
Longeveron Inc
Employees
23
Industry
Biotechnology
CEO
Mr. Mohamed Wa'el Ahmed Hashad M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step